Adipose tissue deficiency of hormone-sensitive lipase causes fatty liver in mice

PLoS Genetics

Volumn 13, Issue 12, 2017, Pages

  Xia, Bo ^a   Cai, Guo He ^a   Yang, Hao ^b   Wang, Shu Pei ^b   Mitchell, Grant A ^b   Wu, Jiang Wei ^a,b  

^a NORTHWEST A F UNIVERSITY   (China)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; HORMONE SENSITIVE LIPASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR; VERY LOW DENSITY LIPOPROTEIN; CHOLESTEROL ESTERASE;

ADIPOSE TISSUE; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENERGY BALANCE; FATTY ACID OXIDATION; FATTY LIVER; GENE EXPRESSION; INSULIN RESISTANCE; LIPODYSTROPHY; MACROPHAGE; MOUSE; NONHUMAN; ANIMAL; DEFICIENCY; DISEASE MODEL; GENETICS; HUMAN; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER; METABOLISM; OBESITY; PATHOLOGY;

ADIPOSE TISSUE; ANIMALS; DISEASE MODELS, ANIMAL; FATTY LIVER; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MICE; MICE, KNOCKOUT; OBESITY; STEROL ESTERASE;

EID: 85040012463     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1007110     Document Type: Article

References (45)

1. Peirce V, Carobbio S, Vidal-Puig A, The different shades of fat. Nature. 2014;510(7503):76–83. doi: 10.1038/nature13477 24899307.
2. Nugent C, Younossi ZM, Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4(8):432–41. doi: 10.1038/ncpgasthep0879 17667992.
3. Brunt EM, Pathology of nonalcoholic fatty liver disease. Nature reviews Gastroenterology & hepatology. 2010;7(4):195–203. doi: 10.1038/nrgastro.2010.21 20195271.
4. Klil-Drori AJ, Azoulay L, Pollak MN, Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?Nat Rev Clin Oncol. 2017;14(2):85–99. doi: 10.1038/nrclinonc.2016.120 27502359.
5. Michelotti GA, Machado MV, Diehl AM, NAFLD, NASH and liver cancer. Nature reviews Gastroenterology & hepatology. 2013;10(11):656–65. doi: 10.1038/nrgastro.2013.183 24080776.
6. Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE, From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nature reviews Gastroenterology & hepatology. 2013;10(11):627–36. doi: 10.1038/nrgastro.2013.149 23958599.
7. Farrell GC, Wong VW, Chitturi S, NAFLD in Asia—as common and important as in the West. Nature reviews Gastroenterology & hepatology. 2013;10(5):307–18. doi: 10.1038/nrgastro.2013.34 23458891.
8. Loomba R, Sanyal AJ, The global NAFLD epidemic. Nature reviews Gastroenterology & hepatology. 2013;10(11):686–90. doi: 10.1038/nrgastro.2013.171 24042449.
9. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, et al. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 2004;306(5700):1383–6. doi: 10.1126/science.1100747 15550674.
10. Haemmerle G, Zimmermann R, Hayn M, Theussl C, Waeg G, Wagner E, et al. Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis. The Journal of biological chemistry. 2002;277(7):4806–15. doi: 10.1074/jbc.M110355200 11717312.
11. Fischer J, Lefevre C, Morava E, Mussini JM, Laforet P, Negre-Salvayre A, et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nature genetics. 2007;39(1):28–30. doi: 10.1038/ng1951 17187067.
12. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006;312(5774):734–7. doi: 10.1126/science.1123965 16675698.
13. Wu JW, Wang SP, Alvarez F, Casavant S, Gauthier N, Abed L, et al. Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis. Hepatology. 2011;54(1):122–32. doi: 10.1002/hep.24338 21465509.
14. Ong KT, Mashek MT, Bu SY, Greenberg AS, Mashek DG, Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology. 2011;53(1):116–26. doi: 10.1002/hep.24006 20967758; PubMed Central PMCID: PMC3025059.
15. Albert JS, Yerges-Armstrong LM, Horenstein RB, Pollin TI, Sreenivasan UT, Chai S, et al. Null Mutation in Hormone-Sensitive Lipase Gene and Risk of Type 2 Diabetes. The New England journal of medicine. 2014. doi: 10.1056/NEJMoa1315496 24848981.
16. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A, et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proceedings of the National Academy of Sciences of the United States of America. 2000;97(2):787–92. 10639158; PubMed Central PMCID: PMC15409.
17. Wang SP, Laurin N, Himms-Hagen J, Rudnicki MA, Levy E, Robert MF, et al. The adipose tissue phenotype of hormone-sensitive lipase deficiency in mice. Obesity research. 2001;9(2):119–28. doi: 10.1038/oby.2001.15 11316346.
18. Roduit R, Masiello P, Wang SP, Li H, Mitchell GA, Prentki M, A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: a study in hormone-sensitive lipase-deficient mice. Diabetes. 2001;50(9):1970–5. 11522661.
19. Mulder H, Sorhede-Winzell M, Contreras JA, Fex M, Strom K, Ploug T, et al. Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact. The Journal of biological chemistry. 2003;278(38):36380–8. doi: 10.1074/jbc.M213032200 12835327.
20. Voshol PJ, Haemmerle G, Ouwens DM, Zimmermann R, Zechner R, Teusink B, et al. Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice. Endocrinology. 2003;144(8):3456–62. doi: 10.1210/en.2002-0036 12865325.
21. Park SY, Kim HJ, Wang S, Higashimori T, Dong J, Kim YJ, et al. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart. American journal of physiology Endocrinology and metabolism. 2005;289(1):E30–9. doi: 10.1152/ajpendo.00251.2004 15701680.
22. Wu JW, Preuss C, Wang SP, Yang H, Ji B, Carter GW, et al. Epistatic interaction between the lipase-encoding genes Pnpla2 and Lipe causes liposarcoma in mice. PLoS Genet. 2017;13(5):e1006716. doi: 10.1371/journal.pgen.1006716 28459858.
23. Ludtke A, Genschel J, Brabant G, Bauditz J, Taupitz M, Koch M, et al. Hepatic steatosis in Dunnigan-type familial partial lipodystrophy. The American journal of gastroenterology. 2005;100(10):2218–24. doi: 10.1111/j.1572-0241.2005.00234.x 16181372.
24. Misra A, Garg A, Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine. 2003;82(2):129–46. 12640189.
25. Cohen JC, Horton JD, Hobbs HH, Human fatty liver disease: old questions and new insights. Science. 2011;332(6037):1519–23. doi: 10.1126/science.1204265 21700865; PubMed Central PMCID: PMC3229276.
26. Minehira K, Young SG, Villanueva CJ, Yetukuri L, Oresic M, Hellerstein MK, et al. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. Journal of lipid research. 2008;49(9):2038–44. doi: 10.1194/jlr.M800248-JLR200 18515909; PubMed Central PMCID: PMC3837456.
27. Fabbrini E, Sullivan S, Klein S, Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679–89. doi: 10.1002/hep.23280 20041406; PubMed Central PMCID: PMC3575093.
28. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G, Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obesity reviews: an official journal of the International Association for the Study of Obesity. 2004;5(1):27–42. 14969505.
29. Softic S, Boucher J, Solheim MH, Fujisaka S, Haering MF, Homan EP, et al. Lipodystrophy Due to Adipose Tissue Specific Insulin Receptor Knockout Results in Progressive NAFLD. Diabetes. 2016. doi: 10.2337/db16-0213 27207510.
30. Lee SA, Yuen JJ, Jiang H, Kahn BB, Blaner WS, Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice. Hepatology. 2016. doi: 10.1002/hep.28659 27227735.
31. Lee PL, Tang Y, Li H, Guertin DA, Raptor/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver disease. Molecular metabolism. 2016;5(6):422–32. doi: 10.1016/j.molmet.2016.04.001 27257602; PubMed Central PMCID: PMC4877665.
32. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356–62. doi: 10.1038/nature03711 16034410.
33. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. The New England journal of medicine. 2006;354(24):2552–63. doi: 10.1056/NEJMoa054862 16775236.
34. Flier JS, Insulin receptors and insulin resistance. Annual review of medicine. 1983;34:145–60. doi: 10.1146/annurev.me.34.020183.001045 6344753.
35. Boucher J, Kleinridders A, Kahn CR, Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harbor perspectives in biology. 2014;6(1). doi: 10.1101/cshperspect.a009191 24384568; PubMed Central PMCID: PMC3941218.
36. Lee DF, Kuo HP, Chen CT, Wei Y, Chou CK, Hung JY, et al. IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. International journal of molecular medicine. 2008;22(5):633–8. doi: 10.3892/ijmm_00000065 18949383; PubMed Central PMCID: PMC2586899.
37. Laplante M, Sabatini DM, mTOR signaling at a glance. Journal of cell science. 2009;122(Pt 20):3589–94. doi: 10.1242/jcs.051011 19812304; PubMed Central PMCID: PMC2758797.
38. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. Journal of lipid research. 2005;46(11):2347–55. doi: 10.1194/jlr.M500294-JLR200 16150820.
39. Bremer AA, Devaraj S, Afify A, Jialal I, Adipose tissue dysregulation in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011;96(11):E1782–8. doi: 10.1210/jc.2011-1577 21865369; PubMed Central PMCID: PMCPMC3205887.
40. Kahn BB, Flier JS, Obesity and insulin resistance. The Journal of clinical investigation. 2000;106(4):473–81. doi: 10.1172/JCI10842 10953022; PubMed Central PMCID: PMCPMC380258.
41. Wu JW, Wang SP, Casavant S, Moreau A, Yang GS, Mitchell GA, Fasting energy homeostasis in mice with adipose deficiency of desnutrin/adipose triglyceride lipase. Endocrinology. 2012;153(5):2198–207. doi: 10.1210/en.2011-1518 22374972.
42. Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell metabolism. 2015;21(5):739–46. doi: 10.1016/j.cmet.2015.04.004 25955209.
43. Fortier M, Soni K, Laurin N, Wang SP, Mauriege P, Jirik FR, et al. Human hormone-sensitive lipase (HSL): expression in white fat corrects the white adipose phenotype of HSL-deficient mice. Journal of lipid research. 2005;46(9):1860–7. doi: 10.1194/jlr.M500081-JLR200 15961788.
44. Wei E, Ben Ali Y, Lyon J, Wang H, Nelson R, Dolinsky VW, et al. Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell metabolism. 2010;11(3):183–93. doi: 10.1016/j.cmet.2010.02.005 20197051.
45. Folch J, Lees M, Sloane Stanley GH, A simple method for the isolation and purification of total lipides from animal tissues. The Journal of biological chemistry. 1957;226(1):497–509. 13428781.